Stephen Gordon, Chief Financial Officer at TransMedics Group, Inc. (TMDX), sold 15,000 shares at $128.00 ($1.9M) on 2024-05-06, disclosed to the SEC on 2024-05-08.
Scheduled sale ($1.9M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TMDX | SELL | 2024-04-02 | $1.1M | — | Filing → |
| TMDX | SELL | 2024-03-12 | $334K | — | Filing → |
| TMDX | SELL | 2024-03-05 | $1.2M | — | Filing → |